Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Osteosarcoma Recurrent × Eflornithine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1 Rhabdoid Tumor 1 Osteosarcoma Recurrent 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Melanoma 1 Lung Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06892678 2025-05-11

DFMO

Montefiore Medical Center

Phase 1/2 Recruiting

Osteosarcoma Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡